CAPTRUST Financial Advisors’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-4
| Closed | – | – | 4653 |
|
|
2022
Q2 | $0 | Hold |
4
| – | – | ﹤0.01% | 5342 |
|
|
2022
Q1 | $0 | Hold |
4
| – | – | ﹤0.01% | 5332 |
|
|
2021
Q4 | $0 | Sell |
4
-150
| -97% | – | ﹤0.01% | 5111 |
|
|
2021
Q3 | $0 | Buy |
154
+150
| +3,750% | – | ﹤0.01% | 4943 |
|
|
2021
Q2 | $0 | Hold |
4
| – | – | ﹤0.01% | 4850 |
|
|
2021
Q1 | $0 | Hold |
4
| – | – | ﹤0.01% | 4636 |
|
|
2020
Q4 | $0 | Hold |
4
| – | – | ﹤0.01% | 3650 |
|
|
2020
Q3 | $0 | Hold |
4
| – | – | ﹤0.01% | 3389 |
|
|
2020
Q2 | $0 | Buy |
+4
| New | – | ﹤0.01% | 2958 |
|
|
2019
Q4 | – | Sell |
-4
| Closed | – | – | 2051 |
|
|
2019
Q3 | $0 | Buy |
+4
| New | – | ﹤0.01% | 2097 |
|
|
2018
Q3 | – | Sell |
-13
| Closed | – | – | 1769 |
|
|
2018
Q2 | $0 | Buy |
+13
| New | – | ﹤0.01% | 1664 |
|